Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3351846rdf:typepubmed:Citationlld:pubmed
pubmed-article:3351846lifeskim:mentionsumls-concept:C0003392lld:lifeskim
pubmed-article:3351846lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:3351846lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:3351846lifeskim:mentionsumls-concept:C0205246lld:lifeskim
pubmed-article:3351846lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:3351846lifeskim:mentionsumls-concept:C0205132lld:lifeskim
pubmed-article:3351846lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:3351846lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:3351846lifeskim:mentionsumls-concept:C0596335lld:lifeskim
pubmed-article:3351846pubmed:issue4lld:pubmed
pubmed-article:3351846pubmed:dateCreated1988-5-10lld:pubmed
pubmed-article:3351846pubmed:abstractTextStructure-antitumor activity relationships are reported for a number of different examples (acridine, phenazine, anthracene, acridone, xanthenone, thioxanthenone, anthraquinone, pyridoquinazoline, dibenzodioxin, thianthrene, phenothiazine, phenoxazine, dibenzofuran, carbazole, and pyridoindole) of the general class of N-[2-(dimethylamino)ethyl] linear tricyclic carboxamides. Only the compounds containing coplanar chromophores intercalated DNA. There is an absolute requirement for an oxygen or aromatic nitrogen (possibly as hydrogen-bond acceptors) peri to the carboxamide, together with a planar ring geometry for biological activity. In addition to further delineating the nature of the pharmacophore for this class of compounds, the work has also identified dibenzo[1,4]dioxin as a novel DNA-intercalating chromophore with in vivo antitumor activity.lld:pubmed
pubmed-article:3351846pubmed:languageenglld:pubmed
pubmed-article:3351846pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3351846pubmed:citationSubsetIMlld:pubmed
pubmed-article:3351846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3351846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3351846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3351846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3351846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3351846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3351846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3351846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3351846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3351846pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3351846pubmed:statusMEDLINElld:pubmed
pubmed-article:3351846pubmed:monthAprlld:pubmed
pubmed-article:3351846pubmed:issn0022-2623lld:pubmed
pubmed-article:3351846pubmed:authorpubmed-author:BaguleyB CBClld:pubmed
pubmed-article:3351846pubmed:authorpubmed-author:DennyW AWAlld:pubmed
pubmed-article:3351846pubmed:authorpubmed-author:AtwellG JGJlld:pubmed
pubmed-article:3351846pubmed:authorpubmed-author:PalmerB DBDlld:pubmed
pubmed-article:3351846pubmed:authorpubmed-author:RewcastleG...lld:pubmed
pubmed-article:3351846pubmed:issnTypePrintlld:pubmed
pubmed-article:3351846pubmed:volume31lld:pubmed
pubmed-article:3351846pubmed:ownerNLMlld:pubmed
pubmed-article:3351846pubmed:authorsCompleteYlld:pubmed
pubmed-article:3351846pubmed:pagination707-12lld:pubmed
pubmed-article:3351846pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:3351846pubmed:meshHeadingpubmed-meshheading:3351846-...lld:pubmed
pubmed-article:3351846pubmed:meshHeadingpubmed-meshheading:3351846-...lld:pubmed
pubmed-article:3351846pubmed:meshHeadingpubmed-meshheading:3351846-...lld:pubmed
pubmed-article:3351846pubmed:meshHeadingpubmed-meshheading:3351846-...lld:pubmed
pubmed-article:3351846pubmed:meshHeadingpubmed-meshheading:3351846-...lld:pubmed
pubmed-article:3351846pubmed:meshHeadingpubmed-meshheading:3351846-...lld:pubmed
pubmed-article:3351846pubmed:meshHeadingpubmed-meshheading:3351846-...lld:pubmed
pubmed-article:3351846pubmed:meshHeadingpubmed-meshheading:3351846-...lld:pubmed
pubmed-article:3351846pubmed:meshHeadingpubmed-meshheading:3351846-...lld:pubmed
pubmed-article:3351846pubmed:meshHeadingpubmed-meshheading:3351846-...lld:pubmed
pubmed-article:3351846pubmed:meshHeadingpubmed-meshheading:3351846-...lld:pubmed
pubmed-article:3351846pubmed:meshHeadingpubmed-meshheading:3351846-...lld:pubmed
pubmed-article:3351846pubmed:meshHeadingpubmed-meshheading:3351846-...lld:pubmed
pubmed-article:3351846pubmed:meshHeadingpubmed-meshheading:3351846-...lld:pubmed
pubmed-article:3351846pubmed:year1988lld:pubmed
pubmed-article:3351846pubmed:articleTitlePotential antitumor agents. 54. Chromophore requirements for in vivo antitumor activity among the general class of linear tricyclic carboxamides.lld:pubmed
pubmed-article:3351846pubmed:affiliationCancer Research Laboratory, University of Auckland School of Medicine, New Zealand.lld:pubmed
pubmed-article:3351846pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3351846pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:3351846lld:chembl